Important News & Announcements

Stay up to date with the latest news and announcements from NASCSA.

UPDATED INFORMATION Alabama PDMP Change to ASAP 4.2b

Posted 9/20/2021

PRE01 National Provider Identifier (NPI) This was sent out as a change in our initial announcement. However, due to Veterinarians not having an NPI number, we are NOT making this a required field. The Field will be SITUATIONAL. DSP13 Partial Fill Indicator This was sent out as a change in our...
Read More

DEA Adjustments to Production Quotas for Schedule I & II CS

Posted 9/12/2021

The Drug Enforcement Administration proposes to adjust the 2021 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act and assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. Read...
Read More

FDA to Host Webinar on Mandatory Prescriber Education

Posted 9/12/2021

The Food & Drug Administration (FDA)  recognizes that there may be new opportunities to improve prescriber education through the Opioid Analgesic Risk Evaluation and Mitigation Strategy and ensure that the education is being delivered in a way that minimizes the burden on the healthcare...
Read More

NY Job Announcement - Deputy Director, BNE

Posted 9/9/2021

The New York Bureau of Narcotic Enforcement (BNE) is looking for a Deputy Director.  The position is responsible for the administration and oversight of the following programs: New York State's Prescription Drug Monitoring Program, Office Prescription Program, Electronic Prescribing,...
Read More

Upcoming Webinar - Sept. 29, 2021 3-4 M

Posted 9/6/2021

Join the National Association of State Controlled Substances Authorities (NASCSA) September 29, 2021 3-4 pm ET for an exclusive look at our new website being launched as a result of the generous contribution of MDScripts.  Speakers: Theo Antoniou, Chief Technology Officer...
Read More

Biden-Harris Administration Provides Recommendations to Congress

Posted 9/3/2021

On September 2, 2021 Regina LaBelle, Acting Director of National Drug Control Policy, presented to Congress the Biden-Harris Administration?s recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances...
Read More

Risky Drug Mixture Gets Riskier When 2 Different Doctors Prescri

Posted 8/18/2021

Benzodiazepines and opioids are two types of medications that act on the brain. Stress, sleeplessness, and worry episodes were treated with benzodiazepines, whereas discomfort is treated with opioids. Since both reduce the desire to breathe, individuals who use opiates and benzodiazepines at a...
Read More

Arizona Newer Reporting Standard Adoption ASAP 4.2B - Nov 1,

Posted 8/13/2021

Good Day, Beginning November 01, 2021, the Arizona CSPMP will be adopting the latest reporting standard from the American Society for Automation in Pharmacy (ASAP). Please read the attached document that contains links to information documents, next steps, and contact information if you...
Read More

Connecticut PDMP Changes to take affect Sept 1, 2021

Posted 8/13/2021

This is to inform you of changes to the Connecticut Prescription Monitoring and Reporting System (CPMRS) that will take place on September 1, 2021.

The CPMRS reporting requirements will be adding and modifying some required, situational, and not required fields in the ASAP 4.2A software...
Read More

Alabama PDMP Change to ASAP 4.2b Dec 1, 2021

Posted 8/13/2021

Beginning December 1, 2021, the Alabama Prescription Drug Monitoring Program (PDMP) will be adopting the latest reporting standard from the American Society for Automation in Pharmacy (ASAP). Please read the attached document that contains links to additional information, next steps, and contact...
Read More

View Earlier Announcements

Sponsor Spotlight

All Sponsors